A single amino acid change makes the peptide specificity of B*3910 unrelated to B*3901 and closer to a group of HLA-B proteins including the malaria-protecting allotype HLA-B53

Tissue Antigens

Volumn 52, Issue 5, 1998, Pages 416-421

  Yague J ^a   Vazquez J ^a   Lopez De Castro J A ^a,b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

B*3910; HLA B39; Malaria; Peptide motifs

Indexed keywords

CYSTEINE; HLA B ANTIGEN; PEPTIDE; TYROSINE;

AFRICA; ALLOTYPE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMAN; HYDROPHOBICITY; MALARIA; PRIORITY JOURNAL; WESTERN HEMISPHERE;

EID: 0031773624     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03067.x     Document Type: Article

References (28)

1. Lopez-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995: 45: 169-76.
2. D'Amato M, Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995: 25: 3199-201.
3. López de Castro JA. HLA-B27 and HLA-A2 subtypes: structure, evolution and function. Immunol Today 1989: 10: 239-46.
4. Rotzschke O, Falk K, Stevanovic S, Jung G, Rammensee HG. Peptide motifs of closely related HLA class I molecules encompass substantial differences. Eur J Immunol 1992: 22: 2453-6.
5. López de Castro JA. The pathogenetic role of HLA-B27 in chronic arthritis. Curr Opin Immunol 1998: 10: 59-66.
6. Luque I, Solana R, Galiani MD et al. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones. Eur J Immunol 1996: 26: 1974-7.
7. Falk K, Rotzschke O, Takiguchi M et al. Peptide motifs of HLA-B38 and B39 molecules. Immunogenetics 1995: 41: 162-4.
8. Yamaguchi A, Tsuchiya N, Mitsui H et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum 1995: 38: 1672-7.
9. Wells RS, Parham P. A novel recombinant HLA-B*39 allele (B*3910) in a South African Zulu. Tissue Antigens 1996: 48: 595-7.
10. Vilches C, Bunce M, de Pablo R et al. The novel HLA-Cw*1802 allele is associated with B*5703 in the Bubi population from Equatorial Guinea. Tissue Antigens 1997: 49: 644-8.
11. de Pablo R, Garcia-Pacheco JM, Vilches C et al. HLA class I and class II allele distribution in the Bubi population from the island of Bioko (Equatorial Guinea). Tissue Antigens 1997: 50: 593-601.
12. Steiner N, Ng J, Bush J, Hartzman RJ, Johnston-Dow L, Hurley CK. HLA-B alleles associated with the B15 serologically defined antigens. Hum Immunol 1997: 56: 84-93.
13. Huczko EL, Bodnar WM, Benjamin D et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 1993: 151: 2572-87.
14. Hill AV, Elvin J, Willis AC et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992: 360: 434-9.
15. Falk K, Rotzschke O, Grahovac B et al. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 1993: 38: 161-2.
16. Smith KJ, Reid SW, Stuart DI, McMichael AJ, Jones EY, Bell JI. An altered position of the α2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 1996: 4: 203-13.
17. Smith KJ, Reid SW, Harlos K et al. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 1996: 4: 215-28.
18. Calvo V, Rojo S, Lopez D, Galocha B, López de Castro JA. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol 1990: 144: 4038-45.
19. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens. New tools for genetic analysis. Cell 1978: 14: 9-20.
20. Garcia F, Galocha B, Villadangos JA et al. HLA-B27 (B*2701) specificity for peptides lacking Arg2 is determined by polymorphism outside the B pocket. Tissue Antigens 1997: 49: 580-7.
21. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991: 351: 290-6.
22. Garcia F, Marina A, Albar JP, López de Castro JA. HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria. Tissue Antigens 1997: 49: 23-8.
23. Wilm M, Mann M. Analytical properties of the nanoelectrospray ion source. Anal Chem 1996: 68: 1-8.
24. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995: 41: 178-228.
25. Sidney J, del Guercio MF, Southwood S et al. Several HLA alleles share overlapping peptide specificities. J Immunol 1995: 154: 247-59.
26. Hill AV, Allsopp CE, Kwiatkowski D et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991: 352: 595-600.
27. Aidoo M, Lalvani A, Allsopp CE et al. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 1995: 345: 1003-7.
28. Plebanski M, Aidoo M, Whittle HC, Hill AV. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J Immunol 1997: 158: 2849-55.